powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1346621927
Andrew Piper
MD
Hematology-Oncology
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
589
Unique beneficiaries
—
Total services
1,254
Distinct HCPCS
7
Medicare payment
$93K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 360 Hematology-Oncology providers in MA — top quintile (cohort median 624).
PRESCRIBING · PART D · 2024
Total Rx claims
1,103
Beneficiaries
—
Total drug cost
$2.6M
Distinct drugs
23
Brand share
16.6%
Top prescribed drugs
Anastrozole
302 claims
Letrozole
118 claims
Osimertinib Mesylate
78 claims
Oxycodone Hcl
77 claims
Prochlorperazine Maleate
74 claims
QUALITY · MIPS · 2024
Final MIPS score
92.0
Quality
76.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.